239 related articles for article (PubMed ID: 15687881)
21. Rotavirus vaccines: safety, efficacy and public health impact.
Gray J
J Intern Med; 2011 Sep; 270(3):206-14. PubMed ID: 21668823
[TBL] [Abstract][Full Text] [Related]
22. Broadening the age restriction for initiating rotavirus vaccination in regions with high rotavirus mortality: benefits of mortality reduction versus risk of fatal intussusception.
Patel MM; Clark AD; Glass RI; Greenberg H; Tate J; Santosham M; Sanderson CF; Steele D; Cortese M; Parashar UD
Vaccine; 2009 May; 27(22):2916-22. PubMed ID: 19428901
[TBL] [Abstract][Full Text] [Related]
23. Rotavirus live, oral, pentavalent vaccine.
Tom-Revzon C
Clin Ther; 2007 Dec; 29(12):2724-37. PubMed ID: 18201590
[TBL] [Abstract][Full Text] [Related]
24. Rotavirus infection and intussusception in Tunisian children: implications for use of attenuated rotavirus vaccines.
Chouikha A; Fodha I; Maazoun K; Ben Brahim M; Hidouri S; Nouri A; Trabelsi A; Steele AD
J Pediatr Surg; 2009 Nov; 44(11):2133-8. PubMed ID: 19944222
[TBL] [Abstract][Full Text] [Related]
25. The new pentavalent rotavirus vaccine composed of bovine (strain WC3) -human rotavirus reassortants.
Clark HF; Offit PA; Plotkin SA; Heaton PM
Pediatr Infect Dis J; 2006 Jul; 25(7):577-83. PubMed ID: 16804425
[TBL] [Abstract][Full Text] [Related]
26. Intussusception and rotavirus vaccines.
Bines J
Vaccine; 2006 May; 24(18):3772-6. PubMed ID: 16099078
[TBL] [Abstract][Full Text] [Related]
27. Active, population-based surveillance for severe rotavirus gastroenteritis in children in the United States.
Payne DC; Staat MA; Edwards KM; Szilagyi PG; Gentsch JR; Stockman LJ; Curns AT; Griffin M; Weinberg GA; Hall CB; Fairbrother G; Alexander J; Parashar UD
Pediatrics; 2008 Dec; 122(6):1235-43. PubMed ID: 19047240
[TBL] [Abstract][Full Text] [Related]
28. Rotavirus vaccines: an update.
Dennehy PH
Curr Opin Pediatr; 2005 Feb; 17(1):88-92. PubMed ID: 15659970
[TBL] [Abstract][Full Text] [Related]
29. Rotavirus surveillance--worldwide, 2001-2008.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2008 Nov; 57(46):1255-7. PubMed ID: 19023263
[TBL] [Abstract][Full Text] [Related]
30. Inactivated rotavirus vaccines: a priority for accelerated vaccine development.
Jiang B; Gentsch JR; Glass RI
Vaccine; 2008 Dec; 26(52):6754-8. PubMed ID: 18951937
[TBL] [Abstract][Full Text] [Related]
31. A hexavalent human rotavirus-bovine rotavirus (UK) reassortant vaccine designed for use in developing countries and delivered in a schedule with the potential to eliminate the risk of intussusception.
Kapikian AZ; Simonsen L; Vesikari T; Hoshino Y; Morens DM; Chanock RM; La Montagne JR; Murphy BR
J Infect Dis; 2005 Sep; 192 Suppl 1():S22-9. PubMed ID: 16088801
[TBL] [Abstract][Full Text] [Related]
32. Intussusception-associated hospitalization among Venezuelan infants during 1998 through 2001: anticipating rotavirus vaccines.
Pérez-Schael I; Escalona M; Salinas B; Materán M; Pérez ME; González G
Pediatr Infect Dis J; 2003 Mar; 22(3):234-9. PubMed ID: 12634584
[TBL] [Abstract][Full Text] [Related]
33. Rotavirus disease and prevention through vaccination.
Marshall GS
Pediatr Infect Dis J; 2009 Apr; 28(4):355-62, quiz 363-4. PubMed ID: 19333083
[TBL] [Abstract][Full Text] [Related]
34. Rotavirus: disease and vaccine update, 2007.
Stebbins S
J Fam Pract; 2007 Feb; 56(2 Suppl Vaccines):S6-11. PubMed ID: 17270111
[TBL] [Abstract][Full Text] [Related]
35. Vaccines: the pentavalent rotavirus vaccine: discovery to licensure and beyond.
Heaton PM; Ciarlet M
Clin Infect Dis; 2007 Dec; 45(12):1618-24. PubMed ID: 18198497
[TBL] [Abstract][Full Text] [Related]
36. Second-year follow-up evaluation of live, attenuated human rotavirus vaccine 89-12 in healthy infants.
Bernstein DI; Sack DA; Reisinger K; Rothstein E; Ward RL
J Infect Dis; 2002 Nov; 186(10):1487-9. PubMed ID: 12404166
[TBL] [Abstract][Full Text] [Related]
37. A critical time for rotavirus vaccines: a review.
Cunliffe NA; Nakagomi O
Expert Rev Vaccines; 2005 Aug; 4(4):521-32. PubMed ID: 16117709
[TBL] [Abstract][Full Text] [Related]
38. A global vaccine for a global disease -- and end to rotavirus diarrhoea?
CVI Forum; 1997 Jun; (14):2-6. PubMed ID: 12293612
[TBL] [Abstract][Full Text] [Related]
39. Rotavirus vaccine AVANT/GlaxoSmithKline.
Jones T
Curr Opin Investig Drugs; 2001 Jul; 2(7):893-5. PubMed ID: 11757786
[TBL] [Abstract][Full Text] [Related]
40. Dose response and efficacy of a live, attenuated human rotavirus vaccine in Mexican infants.
Ruiz-Palacios GM; Guerrero ML; Bautista-Márquez A; Ortega-Gallegos H; Tuz-Dzib F; Reyes-González L; Rosales-Pedraza G; Martínez-López J; Castañón-Acosta E; Cervantes Y; Costa-Clemens S; DeVos B
Pediatrics; 2007 Aug; 120(2):e253-61. PubMed ID: 17606534
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
